Showing results (41-50 of 193) with videos related to
Sort By:
Pageof 20
Alcoholism, Clinical and Experimental Research|April 1, 1979
Genetic factors in Wernicke-Korsakoff syndromeJ P Blass, G E GibsonThe New England Journal of Medicine|December 22, 1977
Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff syndromeJ P Blass, G E GibsonNeurology|April 1, 1988
Clinical significance of the relationship between O-methyldopa levels and levodopa intakeJ M Cedarbaum, H Kutt, F H McDowellNeurology|November 1, 1989
A pharmacokinetic and pharmacodynamic comparison of Sinemet CR (50/200) and standard Sinemet (25/100)J M Cedarbaum, H Kutt, F H McDowellNeurobiology of Aging|January 1, 1984
Regional decline of cerebral blood flow with age in cognitively intact subjectsA Zemcov, L Barclay, J P BlassNeurology|May 1, 1991
"Early" initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson's diseaseJ M Cedarbaum, S E Gandy, F H McDowellAnnals of Neurology|May 1, 1991
Temporal relationships between plasma and cerebrospinal fluid pharmacokinetics of levodopa and clinical effect in Parkinson's diseaseC W Olanow, L L Gauger, J M CedarbaumClinical Neuropharmacology|December 1, 1990
Effect of nitecapone (OR-462) on the pharmacokinetics of levodopa and 3-O-methyldopa formation in cynomolgus monkeysJ M Cedarbaum, G Léger, A Reches, et al.Clinical Neuropharmacology|June 1, 1991
L-deprenyl (selegiline) added to Sinemet CR in the management of Parkinson's disease patients with motor response fluctuationsJ M Cedarbaum, L H Toy, A Green-ParsonsThe Biochemical Journal|April 1, 1975
Decreased synthesis of acetylcholine accompanying impaired oxidation of pyruvic acid in rat brain mincesG E Gibson, R Jope, J P BlassPageof 20